OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
Linda Wordeman, Juan Jesus Vicente
Cancers (2021) Vol. 13, Iss. 22, pp. 5650-5650
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

STIMULI-RESPONSIVE SUPRAMOLECULAR HYDROGELS FOR PACLITAXEL DELIVERY: PROGRESS AND PROSPECTS
Mohammad Qutub, Amol Tatode, Jayshree Taksande, et al.
Aspects of Molecular Medicine (2025) Vol. 5, pp. 100062-100062
Open Access | Times Cited: 5

Microtubule‐targeting agents for cancer treatment: Seven binding sites and three strategies
Xingyu Wang, Benoı̂t Gigant, Xi Zheng, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 30

Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer
Mustafa Emre Gedik, Özge Saatci, Nathaniel Oberholtzer, et al.
Cancer Research (2024) Vol. 84, Iss. 9, pp. 1475-1490
Open Access | Times Cited: 12

Sirtuin dysregulation in Parkinson's disease: Implications of acetylation and deacetylation processes
Sonia Dhiman, Ashi Mannan, Ayushi Taneja, et al.
Life Sciences (2024) Vol. 342, pp. 122537-122537
Closed Access | Times Cited: 10

Molecular and Cellular Involvement in CIPN
Housem Kacem, Annamaria Cimini, Michele d’Angelo, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 751-751
Open Access | Times Cited: 9

From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9

TK216 targets microtubules in Ewing sarcoma cells
Juan Manuel Povedano, Vicky Li, Katherine E. Lake, et al.
Cell chemical biology (2022) Vol. 29, Iss. 8, pp. 1325-1332.e4
Open Access | Times Cited: 37

The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma
Katia Grillone, Caterina Riillo, Roberta Rocca, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10222-10222
Open Access | Times Cited: 31

Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities
Asmaa Ahmed, Mamdouh F. A. Mohamed, Rasha M. Allam, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106171-106171
Closed Access | Times Cited: 29

Microtubules and Cell Division: Potential Pharmacological Targets in Cancer Therapy
Jomon Sebastian, Krishnan Rathinasamy
Current Drug Targets (2023) Vol. 24, Iss. 11, pp. 889-918
Closed Access | Times Cited: 21

Neuronal ageing is promoted by the decay of the microtubule cytoskeleton
Pilar Okenve-Ramos, Rory Gosling, Monika Chojnowska-Monga, et al.
PLoS Biology (2024) Vol. 22, Iss. 3, pp. e3002504-e3002504
Open Access | Times Cited: 6

TUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis
Zaifu Zhu, Wei Zhang, Shaohu Huo, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 6

Structure-based discovery and rational design of microtubule-targeting agents
Michel O. Steinmetz, A.E. Prota
Current Opinion in Structural Biology (2024) Vol. 87, pp. 102845-102845
Open Access | Times Cited: 6

Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway
Jian Song, Shenghui Wang, Chun-Hong Song, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114583-114583
Closed Access | Times Cited: 26

A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo
Yin-Ru Li, Fangfang Liu, Wenbo Liu, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115070-115070
Closed Access | Times Cited: 19

X-ray Crystal Structure-Guided Discovery of Novel Indole Analogues as Colchicine-Binding Site Tubulin Inhibitors with Immune-Potentiating and Antitumor Effects against Melanoma
Yichang Ren, Yuxi Wang, Jin Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 10, pp. 6697-6714
Closed Access | Times Cited: 11

Cyanobacteria: A Promising Source of Antifungal Metabolites
Samuel Cavalcante do Amaral, Luciana Pereira Xavier, Vı́tor Vasconcelos, et al.
Marine Drugs (2023) Vol. 21, Iss. 6, pp. 359-359
Open Access | Times Cited: 11

Progress in the discovery and development of anticancer agents from marine cyanobacteria
Hendrik Luesch, Emma K. Ellis, Qi-Yin Chen, et al.
Natural Product Reports (2024)
Open Access | Times Cited: 4

From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents
Hesham M. Hassan, Roket Hassan, Ranya Mohammed Elmagzoub, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 72-72
Open Access

Synthesis and evaluation of KX-01 analogs with an exploration of linker attachment points for antibody-drug conjugates
Young‐Ho Oh, Dao T. T. An, Jaebeom Park, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130114-130114
Open Access

Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications
Nimeet Desai, Sherrin Gotru, Sagar Salave, et al.
Frontiers in Biomaterials Science (2025) Vol. 4
Open Access

Discovery of a novel microtubule destabilizing agent targeting the colchicine site based on molecular docking
Jinhui Cai, Miao He, Yingying Wang, et al.
Biochemical Pharmacology (2025) Vol. 234, pp. 116804-116804
Closed Access

Endophytic fungi in anticancer drug development: Targeting tumor microenvironment
Yogesh Kumar, Lokesh Gambhir, Gaurav Sharma, et al.
Elsevier eBooks (2025), pp. 75-107
Closed Access

Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Hashini Wanniarachchi, Regan Schuetze, Yuling Deng, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 771-771
Open Access

ARIH1 Inhibition Promotes Microtubule Stability and Sensitizes Breast Cancer Cells to Microtubule-Stabilizing Agents
Mohamed Mahmoud Abdelraheem Elshaer, Breege V. Howley, Philip H. Howe
Cancers (2025) Vol. 17, Iss. 5, pp. 782-782
Open Access

Page 1 - Next Page

Scroll to top